Abstract
An attempt is made to define the usefulness and limitations of carcinoembyonic antigen (CEA) radioimmunoassay for evaluation of diagnosis, tumor resection, and detection of tumor relapse in 108 patients with colorectal carcinoma. Preoperative CEA levels were correlated with pathologic stage and tumor localizations. Increasing levels of CEA were found with the advanced stage of the disease (stage C and D lesions). Our results indicate that 1) an incomplete drop in circulating CEA level one month after surgery is a bad prognostic sign and 2) relapses of colonic and rectal carcinoma can be detected by increased CEA levels months before the appearance of any clinical evidence
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122:467–81.
Fritsche R, Mach JP. Isolation and characterization of carcinoembryonic antigen (CEA) extracted from normal human colon mucosa. Immunochemistry 1977;14:119–27.
Lo Gerfo P, Herter FP. Demonstration of tumor associated antigen in normal colon and lung. J Surg Oncol 1972;4:1–13.
Martin, F, Martin MS. Demonstration of antigens related to colonic cancer in the human digestive system. Int J Cancer 1970;6:352–60.
Chu TM, Reynoso G, Hansen HJ, Demonstration of carcinoembryonic antigen in normal human plasma. Nature 1972;238:152–3.
Herrera MA, Chu TM, Holyoke ED. Carcinoembryonic antigen (CEA) as a prognostic and monitoring test in clinically complete resection of colorectal carcinoma. Ann Surg 1976;183:5–9.
Dukes CE, Bussey HJ. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309–20.
Go VL. Carcinoembryonic antigen: clinical application. Cancer 1976;37:562–6.
Bivins BA, Meeker WR Jr, Griffen WO Jr, Pellegrini J, Parker JC Jr. Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer. J Surg Res 1975;18:257–61.
Holyoke D, Reynoso G, Chu TM. Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. Ann Surg 1972;176:559–64.
Mach JP, Jaeger PH, Bertholet MM, Ruegsegger CH, Loosli RM, Pettavel J. Detection of recurrence of large-bowel carcinoma by radioimmunoassay of circulating carcinoembryonic antigen (CEA). Lancet 1974;2:535–40.
Livingstone AS, Hampson LG, Shuster J, Gold P, Hichey EJ. Carcinoembryonic antigen in the diagnosis and management of colorectal carcinoma: current status. Arch Surg 1974;109:259–64.
Martin EW Jr, Kibbey WE, Di Vicchia L, Anderson G, Catalano P, Minton JP. Carcinoembryonic antigen: clinical and historical aspects. Cancer 1976;37:62–81.
Slater G, Papatestas AE, Aufses AH Jr. Preoperative carcinoembryonic antigen levels in colorectal carcinoma. Arch Surg 1979;114:52–3.
Sorokin JJ, Sugarbaker PH, Zamcheck N, Pisick M, Kupchik HZ, Moore FD. Serial carcinoembryonic antigen assays: use in detection of cancer recurrence. JAMA 1974;228:49–53.
Wood CB, Malcolm AJ, Burt R, Ratcliffe JG, Neville AM, Blumgart LH. Assessment of patients with elevated carcinoembryonic antigen (CEA) levels after, surgery for primary colorectal cancer. Bull Soc Int Chir 1975;5:413–6.
Author information
Authors and Affiliations
About this article
Cite this article
Arnaud, J.P., Koehl, C. & Adloff, M. Carcinoembryonic antigen (CEA) in diagosis and prognosis of colorectal carcinoma. Dis Colon Rectum 23, 141–144 (1980). https://doi.org/10.1007/BF02587615
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02587615